Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome
Highly specialised technologies guidance
Reference number: HST31
Published:
The topic was discussed at the Topic Selection Oversight Panel (TSOP) in March 2022. The panel concluded that the topic was suitable for a Highly Specialised Technologies (HST) evaluation.